Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.